New PET scan could slash radiation by 100x
NCT ID NCT07542158
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new PET imaging technique that uses 10 to 100 times less radiation than standard scans. Researchers will inject 200 healthy volunteers and patients with a radioactive tracer and use a high-sensitivity scanner to see if image quality remains good enough for detecting Parkinsonian syndromes, neuroendocrine tumors, and gliomas. The goal is to make scans safer without losing diagnostic accuracy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- 18F-FDOPA (a radioactive tracer)
- What this could lead to
- If successful, this could make PET scans safer by drastically reducing radiation exposure while maintaining image quality.
- What could go wrong
- This is an early-phase imaging study focused on technical improvements, not a treatment. It may not lead to changes in patient care or diagnosis.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOMAS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nuclear Imaging Institute
Englewood, New Jersey, 07631, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain tumor drug vorasidenib tested in everyday practice
- Zapping the brain without surgery: a new hope for Parkinson's?
- New hope for rare gut tumors? phase 2 trial launches
- AI reads MRI scans to predict brain tumor type before surgery
- Brain tumor chemo delivered by pump shows promise in tiny safety trial
- New study aims to reduce harmful side effects in rare cancer patients